Quick answer
- Yes, PMOS is linked to higher heart disease risk, and the increase is smaller than most articles imply. Across 20 studies and 1.06 million women, the odds of a cardiovascular event were 1.68 times higher than in women without PMOS.
- Cardiovascular death was not clearly raised, and the researchers who ran that review rated the certainty of the evidence as low, because every study is observational.
- Belly fat is the main pathway, not the whole story. When studies accounted for body weight, the excess risk fell from roughly 2-fold to 1.55-fold. It halved and it did not vanish.
- Visceral fat harms arteries through four routes at once: a specific lipid pattern (high triglycerides, low HDL, more small dense LDL), chronic inflammation, insulin resistance, and higher blood pressure.
- Your waist tells you more than the scale. In a 2026 study of 259,388 people, 18 percent of those at a normal weight carried elevated central adiposity that BMI never flagged.
- The risk is modifiable, which is the point. Six numbers are worth checking, and all six respond to food, movement and sleep rather than to worry.
Want meals built around the insulin and lipid side of this? Get a heart-friendly PMOS plan.
PMOS belly fat and heart disease are genuinely connected, and the size of the risk is smaller than most articles imply. Across 20 studies covering 1.06 million women, PMOS (the new name for PCOS as of 12 May 2026) carried 1.68 times the odds of a cardiovascular event. Cardiovascular death was not clearly raised, and the reviewers rated their own evidence as low certainty because all of it is observational. Belly fat is the main pathway: accounting for body weight cuts the excess risk roughly in half, though it does not erase it. This article covers what the numbers actually mean, why visceral fat damages arteries through four routes at once, the six measurements worth getting, and what lowers the risk.
Does PMOS increase your risk of heart disease?
Yes, the association is consistent across large studies, though the increase is modest and the evidence is weaker than the confident headlines suggest. The systematic review that informed the 2023 International Evidence-Based Guideline pooled 20 studies covering 1.06 million women, 369,317 of them with PMOS. Here is what it found.
| Outcome | Odds ratio in PMOS | What it means |
|---|---|---|
| Any cardiovascular event | 1.68 (95% CI 1.26 to 2.23) | Raised, and the interval does not cross 1, so the finding is statistically solid |
| Heart attack | 2.50 (95% CI 1.43 to 4.38) | The largest single signal, though the wide interval means the true value is imprecise |
| Stroke | 1.71 (95% CI 1.20 to 2.44) | Raised |
| Ischaemic heart disease | 1.48 (95% CI 1.07 to 2.05) | Raised, only just |
| Cardiovascular death | 1.19 (95% CI 0.53 to 2.69) | Not clearly raised. The interval crosses 1, so this could be no difference at all. |
That last row rarely makes it into PMOS content, and it should. A separate meta-analysis of 10 cohort studies covering 166,682 women (Zhang and colleagues, 2020) found the same thing: cardiovascular events were raised, while cardiovascular mortality (HR 1.49, 95% CI 0.99 to 2.23) and all-cause mortality (HR 1.04, 95% CI 0.57 to 1.86) were not statistically raised.
The guideline reviewers also rated the certainty of their own findings as low, because every study feeding into them was observational. Observational studies can show that two things travel together. They cannot prove one caused the other, and they cannot fully rule out that some third factor explains both. So the fair summary is: a real and repeatable association, a modest effect size, unclear effect on dying from heart disease, and low certainty overall.
How much of the heart risk comes from belly fat?
Roughly half, and this is the most useful number in the whole topic. de Groot and colleagues (2011), publishing in Human Reproduction Update, pooled five follow-up studies and found a relative risk of 2.02 for coronary heart disease or stroke in PCOS (95% CI 1.47 to 2.76). They then pooled only the studies whose risk estimates had been adjusted for BMI. In that subset the relative risk fell to 1.55 (95% CI 1.27 to 1.89).
What that shift actually tells you
The excess risk dropped from about 2-fold to about 1.55-fold once body weight was taken into account. It halved. It also did not disappear.
Both halves of that sentence matter. Because it halved, central fat is the single biggest lever available to you, and working on it is not wishful thinking. Because it did not disappear, something about PMOS itself contributes independently, most likely insulin resistance and raised androgens, so a woman at a perfectly ordinary weight is not exempt.
One caveat worth stating plainly: only two studies in that pooled analysis carried BMI-adjusted estimates, so the 1.55 figure rests on a thin base. It is the best direct evidence available on the question, and it is not a precise measurement. Treat it as a rough split rather than a settled ratio.
Why does belly fat damage arteries?
Because visceral fat works on your arteries through four routes at the same time, which is why it shows up across so many unrelated-looking blood tests. Visceral fat is the fat stored inside your abdominal wall around your organs, not the soft layer you can pinch. The distinction matters here because the two behave differently, as set out in what causes visceral fat.
1. It shifts your lipids toward the plaque-building pattern
High visceral fat is associated with a specific and recognisable lipid signature: triglycerides up, HDL cholesterol down, apolipoprotein B up, and a shift toward small dense LDL particles. Clinicians call this atherogenic dyslipidemia, meaning the pattern that builds plaque. Small dense LDL particles matter because they slip into artery walls more easily than large ones and oxidise more readily once there. This is why your total cholesterol can look acceptable while the underlying particle picture is not.
2. It keeps inflammation running
Visceral fat releases inflammatory signalling molecules continuously, and per gram it releases more of them than subcutaneous fat does. That low-grade inflammation shows up as raised hs-CRP, and it damages the endothelium, the single-cell lining of your blood vessels. A damaged endothelium is where plaque starts.
3. It worsens insulin resistance
Visceral fat drains into the portal vein, so the fatty acids it releases arrive at your liver first and undiluted. The liver responds by making more glucose and more triglycerides, and insulin rises to compensate. Persistently high blood sugar and insulin both injure vessel linings. This is also the loop that makes the whole thing self-sustaining, because insulin resistance encourages more visceral storage.
4. It raises blood pressure
Central adiposity is consistently linked to higher blood pressure, which adds mechanical strain to arteries already stiffened by the first three mechanisms. Blood pressure is also the fastest of the four to respond to change, which makes it a useful early signal that something is working.
Notice that no single blood test captures all four. That is the argument for checking a small panel rather than one number, and for reading them together.
What does the risk actually mean for you?
An odds ratio of 1.68 sounds alarming and is frequently written up as though a diagnosis were a sentence. It is not. Understanding why requires one distinction that most PMOS content skips: the difference between relative and absolute risk.
Relative risk describes how your risk compares with someone else's. Absolute risk describes your actual chance of something happening in a given period. A 1.68-fold increase applied to a very small baseline produces a slightly larger but still very small number. For a woman in her twenties or thirties, the chance of a cardiovascular event in any given year is low, so 1.68 times that remains low.
What the figure genuinely tells you is about direction over decades. Plaque accumulates quietly across years, long before anything is felt, and the four mechanisms above are all running in the background during that time. That is an argument for measuring early and adjusting habits while it is easy, not an argument for alarm.
Two things are true at once, and holding both is the honest position. This risk is real, repeatable across a million women, and worth acting on. It is also modest, uncertain, not clearly linked to dying of heart disease, and among the most modifiable parts of PMOS. If you have just read something frightening about PMOS and your heart, that combination is the accurate picture.
Why your waist tells you more than the scale
Because BMI cannot see where fat is stored, and location is what drives cardiovascular risk. This is no longer a fringe point. The Cross-Cohort Collaboration analysis published in the Journal of the American College of Cardiology in 2026 examined 259,388 people across 15 datasets with a median of about 20 years of follow-up, across nine cardiovascular outcomes.
Among people at a normal weight, 18 percent had an elevated waist-to-hip ratio, which the authors called hidden elevated risk. Among people in the overweight range, around 40 percent had high waist measurements. For both groups, a high waist measurement raised cardiovascular risk by 15 to 50 percent depending on the outcome. Among people with obesity, elevated waist circumference accounted for 49 percent of heart failure events and 46 percent of atrial fibrillation events. The authors concluded that relying on BMI alone misclassifies cardiovascular risk.
For PMOS this matters twice over, because androgens push fat storage toward the abdomen rather than the hips and thighs. Two women at the same weight can carry very different amounts of visceral fat, and the one with more of it carries more risk. If you have lean PMOS, the scale is the least informative measurement available to you.
| Waist-to-height ratio | NICE classification |
|---|---|
| 0.4 to 0.49 | Healthy. No increased health risk from central fat. |
| 0.5 to 0.59 | Increased central adiposity, with increased health risk. |
| 0.6 and above | High central adiposity, with further increased risk. |
Measure at the midpoint between your lowest rib and the top of your hip bone, at the end of a normal breath out, and divide by your height in the same units. The one-line version NICE leads with: keep your waist to less than half your height.
Which six numbers should you get checked?
Six measurements describe cardiovascular risk in PMOS. One you can do at home today. The other five need a doctor, and two of them are commonly left off routine panels unless you ask by name.
| Measurement | General target | Why it matters here |
|---|---|---|
| Waist-to-height ratio | Under 0.5 | The closest home proxy for visceral fat, and free |
| Blood pressure | Below 120/80 is optimal; treatment thresholds vary by guideline | Mechanical strain on arteries, and the fastest marker to respond |
| Triglycerides | Under 1.7 mmol/L (150 mg/dL) | Rises first with visceral fat and insulin resistance |
| HDL cholesterol | Above 1.3 mmol/L (50 mg/dL) for women | Falls as visceral fat rises; the ratio with triglycerides is telling |
| HbA1c and fasting insulin | HbA1c under 42 mmol/mol (5.7%) | Ask for fasting insulin by name. It can be high for years while glucose reads normal. |
| hs-CRP | Under 2 mg/L | The inflammation route, and often not offered unless requested |
Those targets come from widely used ADA and AHA reference standards and are general orientation, not personal advice. Reference ranges differ between labs and countries, and your doctor interprets them against your full picture. Ask for non-HDL cholesterol as well, which is simply total cholesterol minus HDL, because it captures every particle type that contributes to plaque rather than LDL alone. Which foods move each of these is covered in the PMOS blood markers guide.
What lowers the heart risk from PMOS belly fat?
Because belly fat is the main pathway, the list that lowers visceral fat is largely the list that lowers cardiovascular risk. Five things, in rough order of return on effort.
1. Aerobic exercise, including when your weight does not change
Meta-analyses of randomised trials show visceral fat falling with exercise alone, without any dietary change. Moderate to vigorous aerobic work has a larger effect than low-intensity work. Exercise also improves blood pressure, triglycerides and HDL independently, so it acts on three of the four mechanisms at once. A flat scale is not evidence that nothing is happening. Building the habit is covered in the PMOS exercise guide.
2. Eat the Mediterranean-style pattern
Of all the eating patterns studied for cardiovascular outcomes, the Mediterranean-style pattern has the strongest evidence base: vegetables, legumes, whole grains, olive oil, nuts, fish, with little processed meat and few refined carbohydrates. It happens to also be an insulin-friendly pattern, which is why it suits PMOS on both counts. The evidence and the adherence problem are set out in Mediterranean diet adherence in PCOS. Meals in that shape include ginger sesame glazed salmon, red lentil and sweet potato curry, and spicy chickpea chole.
3. Cut sugar-sweetened drinks
Sugar-sweetened beverage intake is linked to visceral fat gain independently of overall weight change, and liquid sugar also drives triglycerides up directly. If you drink one most days, this is the highest-yield single swap on the list.
4. Protein and fibre at every meal
This is the insulin lever, and insulin sits behind both the storage and the lipid picture. Soluble fibre from oats, beans, lentils and psyllium also lowers LDL cholesterol on its own, so this change acts on two mechanisms. A palm-sized portion of protein plus vegetables or legumes at each meal does most of the work.
5. Sleep seven to nine hours, and get snoring checked
Short sleep raises visceral fat and blood pressure. Untreated sleep apnoea, which is more common with PMOS, independently raises cardiovascular risk and undermines every other lever here. If you snore heavily, wake unrefreshed, or someone has noticed you stop breathing, that is worth raising with your doctor rather than treating as a sleep-hygiene problem.
The 80/20 here: brisk walking most days plus cutting sugar-sweetened drinks. Those two need no equipment, no supplement and no new skill, and between them they act on all four mechanisms in the diagram above.
What does not lower the risk
- Worrying about it. Said plainly because this topic generates a lot of fear and fear moves none of the six numbers.
- Ab exercises. They build the muscle under the fat. Spot reduction of fat at a chosen site is not something bodies do.
- Cholesterol-lowering supplements bought on the strength of a label. If your lipids are raised enough to matter, that is a treatment conversation with a doctor, not a supplement decision.
- Cutting dietary fat specifically. The lipid pattern driven by visceral fat responds to refined carbohydrate, liquid sugar and insulin more than to fat intake. Olive oil, nuts and oily fish are part of the fix.
- Crash dieting. It costs muscle, which is the tissue that absorbs glucose, and the weight regain that usually follows tends to return as visceral fat.
When should you see a doctor?
Book a routine appointment to get the six numbers checked if you have PMOS and have never had them done, particularly if your waist-to-height ratio is 0.5 or above, or if you have a family history of early heart disease. This is a normal, unhurried conversation to have.
Seek urgent medical help for symptoms rather than for risk factors. Chest pain or pressure, pain spreading to the arm, jaw, neck or back, sudden breathlessness, sudden weakness or numbness on one side, and sudden difficulty speaking all need emergency care immediately, not an appointment. Heart attack symptoms in women more often present as breathlessness, nausea, unusual fatigue or jaw and back pain rather than the classic chest-clutching picture, which is one reason they get dismissed. If something feels acutely wrong, treat it as urgent.
The 60-second heart risk self-check
Score one point for each statement that is true for you. This is not a diagnosis or a validated risk score. It is a way to see which levers apply to you, and what to raise at your next appointment.
- My waist-to-height ratio is 0.5 or above.
- I have never had my cholesterol or triglycerides checked.
- I do not know what my blood pressure is.
- I have been told my triglycerides are high, or my HDL is low.
- I drink at least one sugar-sweetened drink on most days, including juice.
- I do fewer than two sessions of deliberate exercise in a normal week.
- I usually sleep under seven hours, snore heavily, or wake unrefreshed.
- I smoke, or I vape nicotine.
- A parent or sibling had heart disease or a stroke before age 60.
- I have been told I have insulin resistance, prediabetes or type 2 diabetes.
0 to 2: Little to act on. Measure your waist-to-height ratio once a month so you notice drift early, and get the bloods done at your next routine appointment.
3 to 5: You have found two or three specific levers rather than a vague worry. Book an appointment for the six numbers, and start with whichever habit on your list is easiest to change.
6 or more: Worth an appointment reasonably soon, with this list in hand. Several drivers are stacking, and the smoking and family-history items in particular change how a doctor will assess your overall risk. This is information, not a verdict.
Whatever you scored, the food side is the part you act on three times a day. The PCOS Meal Planner builds meals in the protein, fibre and Mediterranean-style shape that moves all six numbers, matched to your symptoms and what you actually like eating.
Myths about PMOS and heart disease
Myth: PMOS means you will get heart disease.
Reality: It means a modestly higher chance. Across 1.06 million women the odds of a cardiovascular event were 1.68 times higher, and cardiovascular death was not clearly raised at all. A raised relative risk on a small baseline is still a small absolute risk.
Myth: The heart risk is entirely explained by carrying extra weight.
Reality: Roughly half of it. Adjusting for BMI cut the excess risk from 2.02-fold to 1.55-fold. It halved and it did not vanish, which is why a woman at an ordinary weight is not exempt.
Myth: A normal BMI means your heart is fine.
Reality: In a 2026 analysis of 259,388 people, 18 percent of those at a normal weight had elevated central adiposity that BMI never flagged. The authors called it hidden elevated risk. Measure your waist.
Myth: Normal total cholesterol means your lipids are fine.
Reality: Visceral fat produces a pattern total cholesterol can hide: triglycerides up, HDL down, and a shift toward small dense LDL particles. Ask for triglycerides, HDL and non-HDL cholesterol, not just the headline number.
Myth: You are too young to think about this.
Reality: Plaque builds quietly over decades and the four mechanisms run in the background the whole time. Being young is the reason to measure now, while changing the trajectory is still easy, not a reason to wait.
Myth: The research on this is settled.
Reality: The reviewers behind the 2023 guideline rated the certainty of their own findings as low, because every study is observational. The association is consistent and the precise size of it is not. Anyone quoting a single confident figure is overselling.
Frequently asked questions
Does PMOS cause heart disease?
PMOS is associated with more cardiovascular events, though association is not proof of cause. The review behind the 2023 International Evidence-Based Guideline pooled 20 studies and 1.06 million women: composite cardiovascular events 1.68 times the odds (95% CI 1.26 to 2.23), heart attack 2.50, stroke 1.71. Cardiovascular death was not clearly raised (1.19, 95% CI 0.53 to 2.69). The authors rated certainty as low, since all the evidence is observational.
How much of the heart risk in PMOS comes from belly fat?
Roughly half. de Groot and colleagues (2011) found a relative risk of 2.02 for coronary heart disease or stroke, falling to 1.55 in the studies adjusted for BMI. So body weight and central fat carry about half the excess risk, while something about PMOS itself, most likely insulin resistance and raised androgens, contributes independently. Only two studies carried BMI-adjusted estimates, so treat it as a rough split.
Why does belly fat specifically damage your heart?
Visceral fat acts through four routes at once. It shifts lipids toward the plaque-building pattern (triglycerides up, HDL down, more small dense LDL). It releases inflammatory signals, raising hs-CRP. It worsens insulin resistance, and high glucose and insulin injure vessel linings. And it raises blood pressure. Subcutaneous fat, the pinchable layer, does far less of this because it drains into general circulation rather than into the liver.
Should I be worried about my heart if I have PMOS?
Concerned enough to get six numbers checked, not frightened. An odds ratio of 1.68 is relative, and applied to the small baseline risk of a woman in her twenties or thirties it remains a small absolute risk. What matters is the direction over decades, since plaque builds quietly. Cardiovascular risk is among the most modifiable parts of PMOS. Worry moves none of the six numbers; food, movement and sleep move all six.
Can you have heart risk from PMOS at a normal weight?
Yes. BMI cannot see where fat sits, and location drives the risk. In the Cross-Cohort Collaboration analysis (JACC, 2026), covering 259,388 people over about 20 years, 18 percent of normal-weight people had an elevated waist-to-hip ratio the authors called hidden elevated risk, and high waist measurements raised risk by 15 to 50 percent across outcomes. With lean PMOS the same insulin and androgen picture applies without raised weight.
Which numbers should I ask my doctor for?
Six: waist-to-height ratio (do this at home, target under 0.5), blood pressure, a full lipid panel with triglycerides and HDL plus non-HDL cholesterol, HbA1c, fasting insulin, and hs-CRP. Fasting insulin and hs-CRP are often left off routine panels, so ask for them by name. Say you have PMOS and are asking about cardiovascular risk assessment, because that framing changes what gets ordered.
What lowers heart disease risk with PMOS?
Largely the list that lowers visceral fat, since that is the main pathway. Aerobic exercise, which works even when your weight does not change. The Mediterranean-style eating pattern, which has the strongest cardiovascular evidence base and happens to be insulin-friendly. Cutting sugar-sweetened drinks. Protein and fibre at every meal. Seven to nine hours of sleep, with snoring investigated. If blood pressure or lipids are already raised, treatment is a separate conversation with your doctor.
Does losing belly fat reverse the heart risk from PMOS?
It lowers it substantially, and no honest source can promise it removes it. Around half the excess risk appears to travel through body weight and central fat, so reducing visceral fat addresses the largest single component, and all four mechanisms improve as it falls. What no study can tell you is your personal outcome, because these are population averages from observational data. Expect meaningful improvement in every marker that predicts risk.
Sources and further reading
Cardiovascular events in PCOS
- 2023 International Evidence-Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta-Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome. J Am Heart Assoc. 2024
- Zhang J, Xu JH, Qu QQ, Zhong GQ. Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: a meta-analysis of cohort studies. Front Cardiovasc Med. 2020
How much of the risk travels through body weight
Waist measurement versus BMI for cardiovascular risk
- Dardari ZA, et al. Risk reclassification beyond BMI by waist circumference and waist-to-hip ratio across 9 cardiovascular outcomes: results from the Cross-Cohort Collaboration. J Am Coll Cardiol. 2026;88:670-684
- NICE NG246: Identifying and assessing overweight, obesity and central adiposity
Clinical guidelines and patient-facing summaries
- International Evidence-Based Guideline for the Assessment and Management of PCOS (Monash)
- NHS: Polycystic ovary syndrome (PCOS)
- British Heart Foundation: cardiovascular risk factors
Your next three steps
- Measure your waist-to-height ratio today. Thirty seconds and a tape measure. Write it down with the date, because the trend is the useful part.
- Book an appointment for the other five numbers if you have never had them checked. Take the six-item list with you, and ask for fasting insulin and hs-CRP by name.
- Change one habit, not five. Pick the easiest item you scored in the self-check and hold it for a month. Brisk walking most days is the usual best first move.
How this article was made
The event figures come from the systematic review and meta-analysis informing the 2023 International Evidence-Based PCOS Guideline, published in the Journal of the American Heart Association in 2024, covering 20 studies and 1.06 million women. Both the raised event odds and the unclear cardiovascular mortality finding are reported here, along with the authors' own low certainty rating, rather than only the figures that make a cleaner story. The mortality nulls are corroborated by Zhang et al. 2020 in Frontiers in Cardiovascular Medicine (10 cohorts, 166,682 women). The BMI-adjustment comparison, a relative risk of 2.02 falling to 1.55, is from de Groot et al. 2011 in Human Reproduction Update; only two of its five studies carried BMI-adjusted estimates, which is stated in the body because it limits how much weight that split can bear. The waist-versus-BMI data are from Dardari et al. 2026 in the Journal of the American College of Cardiology (259,388 people, 15 datasets, around 20 years of follow-up, 9 outcomes). Waist-to-height thresholds are from NICE guideline NG246. The four mechanisms are described as established physiology rather than sourced to a single trial. Target ranges are general orientation from widely used ADA and AHA reference standards; laboratory ranges differ, and only your doctor can interpret yours. All of the underlying evidence is observational, so it shows association rather than proof of cause. PMOS is the new name for PCOS as of 12 May 2026; the underlying biology is unchanged. This article is informational and not medical advice. For chest pain, sudden breathlessness or sudden one-sided weakness, seek emergency care immediately.
Community Comments
Add a comment